Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Contraceptive Technology Update

RSS  

Articles

  • Warn patients about bogus at-home tests

    The Food and Drug Administration (FDA) has issued an alert concerning use of unapproved home-use diagnostic test kits marketed over the Internet.
  • New research in: Patch is cost-effective

    New research indicates that use of the contraceptive patch results in greater cost savings and reductions in pregnancy, compared with combination oral contraceptives, due to improved compliance by patients.
  • Does increased weight impact OC efficacy?

    Results of new research suggest that being overweight may increase womens risk of becoming pregnant while using oral contraceptives. How do these findings play into contraceptive counseling for clinicians?
  • Men next target in HPV research drive

    Researchers are taking a hard look at the forgotten half of the transmission equation of human papillomavirus (HPV). Investigators are recruiting 3,000 healthy men, ages 18 to 44, in the United States, Mexico, and Brazil to determine mens roles in spreading the sexually transmitted organism, which is linked to cervical cancer in women.
  • Up the radar for LGV: New cases reported

    Put your diagnostic skills into high gear to spot lymphogranuloma venereum (LGV), a sexually transmitted disease caused by a type of Chlamydia trachomatis.
  • Ask the Experts: Answers to questions on intrauterine devices, EC

    What is your approach when checking for copper allergy in women considering use of the Copper T380A (ParaGard, FEI, Addison, TX)? What are your directions on use of the levonorgestrel-only EC, Plan B (Barr Pharmaceuticals, Pomona, NY)?
  • Washington Watch: Adoption program undergoes changes

    In late September 2004, the Department of Health and Human Services announced a new round of national and regional grantees for the infant adoption awareness-training program. Given the dubious track record of this program during its first three years of operation, many family planning providers are hopeful that this will bring much-needed changes to the national training curriculum.
  • NuvaRing not affected by heavier body weight

    The next patient in your exam room is in her mid-20s. While she is in generally good health, you note she weighs in at 210 pounds. What contraceptive methods do you offer her?
  • Research eyes new sterilization option

    Investigators now are looking at a transcervical sterilization option that, if proven safe and effective, will give women another alternative for permanent contraception.
  • Teens & dysmenorrhea: Look to low-dose OCs

    The 15-year-old young woman in your exam room tells you that she has crampy pelvic pain that begins shortly before or at the onset of her menstrual period that lasts one to three days. She says she usually misses a day of school each month due to the pain. What is your next move?